Glenmark Sets Up Clinical R&D Unit At Oxford As Drug Pipeline Swells

MUMBAI - Glenmark Pharmaceuticals, one of India's fastest growing research-based drug companies, has set up a new clinical research and development outfit at Oxford Science and Business Park in the United Kingdom

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip